Clinical Trial Update: CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a CRP regimen for elderly patients with previously untreated double-positive diffuse large B-cell lymphoma, and the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CRP regimen

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 | Status: RECRUITING